Close

Enter a search request and press enter. Press Esc or the X to close.

A Specialty Pharmacy Network.

Drive New Revenue, Improve Patient Care, Control Costs for At-Risk Populations

The specialty drug market is projected to reach $250 billion in 2020 – representing greater than 50% of pharmacy plan spend. Without an effective specialty and ambulatory pharmacy strategy in place, hospitals and health systems alike will struggle to meet the challenges presented from specialty treatments:

  • Specialty medications often come at a high cost – most over $2,000 per fill
  • Less than 2% of the patient population requires specialty drugs
  • Specialty medications are often associated with complex administration and compliance issues
  • Product manufacturers may choose to limit specialty drug distribution

340B eligible hospitals and health systems are ideal candidates for specialty pharmacy services.

THE IMPACT OF SPECIALTY DRUGS

< 2%

of patients require specialty drugs

50%

of Rx costs are driven by specialty drugs

Experience the Difference

SPARx provides expertise and industry power to help you define your own successful specialty and ambulatory pharmacy strategy. Our experts help you craft a best-in-class strategy inclusive of retail pharmacy, specialty pharmacy and infusion services that will maximize your pharmacy revenue, enable greater patient care quality and align resources and sites of care for optimal reimbursement and patient satisfaction.

Without a strong Specialty Pharmacy capability, healthcare organizations are at risk of losing millions in revenue from those medications and related ambulatory care services.

Keith Cook, President of SPARx